NR4A1 and breast neoplasm: Conversely, the HER2-E subtype seems to capture some, but not all clinically HER2+ tumors, while HER2-E tumors can be identified within HER2-negative breast tumors, both in hormone receptor-positive or negative profiling (5, 6, 37, 44).